This page shows the latest ACT therapy news and features for those working in and with pharma, biotech and healthcare.
faster. That requires governments, private enterprise, and philanthropic organisations to act quickly to fund R&D,” he added.
body - a “complete, durable regression” in the words of the scientists that developed the therapy. ... The ACT approach used by the researchers differs a little from chimeric antigen receptor T cell or CAR-T therapy, which have been approved for use
ALKS 5461 is being developed as a once-daily therapy administered as a sublingual tablet. ... Brexpiprazole is a dopamine D2 partial agonist being developed as an oral adjunctive therapy.
In Tanzania, stock-outs of antimalarial treatment (Novartis' fixed-dose artemisinin-based combination therapy, or ACT, and quinine injectables) dropped from 79 per cent to less than 26 per cent in ... 2010 following the programme's debut, and the number
No proof of an added benefit of aclidinium bromide compared with the appropriate comparator therapy (ACT) can be inferred from the data in the drug manufacturer's dossier,” it concluded.
use. Moreover, there is a critical need for new malaria drugs in the face of emerging resistance even to the most effective artemisinin-based combination therapy (ACT) which was first encountered
More from news
Approximately 1 fully matching, plus 8 partially matching documents found.
These individuals are highly trained in therapy and product science and should have either a PhD in research or medical or a pharmacy background. ... Though the educational material must be unbiased toward a specific product, when well developed the
More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.
W2O Group is an integrated marketing agency with expertise in brand and digital strategy, creative development and communications services. We...